Resectoscope Devices Market – By Type, By Application, By End Use, Global Forecast, 2025 to 2034

Resectoscope Devices Market Size

The global resectoscope devices market size was valued at USD 402.2 million in 2024 and is expected to exhibit growth at a CAGR of 5.7% from 2025 to 2034 period. The market growth is attributed to the rising prevalence of urological and gynecological disorders and the shift towards minimally invasive procedures.
 

As conditions such as benign prostatic hyperplasia (BPH) and bladder cancer become more prevalent worldwide, the demand for transurethral resection procedures is on the rise. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately 50% of men aged 51 to 60 experience BPH, further driving the need for such procedures. In these minimally invasive treatments, resectoscopes play a crucial role, delivering precision and shortening recovery times in contrast to conventional surgeries.
 

Resectoscope devices are specialized medical instruments used primarily in urology and gynecology for performing minimally invasive procedures. These devices are equipped with a light source, irrigation system, and electrosurgical devices, enabling precise resection of tissue from the bladder, prostate, or uterus.  

Resectoscope Devices Market Trends

The market is witnessing significant growth fueled by continuous technological advancements, which are revolutionizing the efficiency, safety, and precision of surgical procedures. These advancements are driving the adoption of resectoscope devices across various medical disciplines, particularly in urology and gynecology.
 

• Modern resectoscope devices are equipped with high-definition imaging systems and advanced optics that provide surgeons with improved visibility during procedures. This enhances precision and reduces the risk of complications, especially in delicate surgeries like transurethral resection of the prostate (TURP).
   
• Additionally, innovations in energy-based technologies, such as bipolar and laser systems, are increasingly integrated with resectoscope devices. These modalities improved tissue cutting, coagulation, and ablation, allowing for minimally invasive procedures with faster recovery times and reduced patient discomfort.
   
• Furthermore, innovations like enhanced insulation of instruments and automated energy controls minimize the risks of tissue damage or unintended injuries. These features are crucial for ensuring patient safety and improving surgical outcomes.
   

Resectoscope Devices Market Analysis

Based on type, the market is segmented as monopolar resectoscopes, bipolar resectoscopes, and hybrid resectoscopes. The monopolar resectoscopes segment is expected to drive business growth and expand at a CAGR of 5.5%, reaching over USD 327.3 million by 2034.
 

• Monopolar resectoscopes are extensively utilized for transurethral resection of the prostate (TURP) and other bladder-related surgeries. In gynecology, they are favored for procedures like hysteroscopic surgeries, ensuring effective treatment outcomes.
   
• Compared to bipolar systems, monopolar resectoscopes are often more cost-effective, making them an attractive choice for healthcare facilities with budget constraints. This affordability ensures their widespread adoption in both developed and emerging markets.
   

Based on application, the resectoscope devices market is segmented as urology, gynecology, general surgery, and other applications. The urology segment is expected to drive business growth and expand at a CAGR of 5.8%, reaching over USD 294.6 million by 2034.
 

• An aging global population has significantly increased the prevalence of urological conditions such as prostate enlargement and bladder cancer. These conditions often necessitate surgical interventions where resectoscopes are critical, fueling demand for this minimally invasive surgical instrument.
   
• Urology has been at the forefront of adopting minimally invasive procedures, including transurethral resection of the prostate (TURP) and bladder tumor resection. Resectoscopes, designed for precision and efficiency in these procedures, are in high demand, especially in developed healthcare markets.
   

Based on end use, the resectoscope devices market is classified into hospitals, clinics, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 45.6% in 2024.
 

• Equipped with state-of-the-art operating theaters and advanced imaging technologies, hospitals ensure optimal use of resectoscope devices. Their ability to integrate these tools into complex surgical workflows further reinforces their dominance.
   
• The presence of urologists, gynecologists, and other specialists who are proficient in using resectoscope devices ensures precision and safety during procedures. This expertise aligns hospitals as the preferred setting for complex and minimally invasive surgeries.
   

The U.S. resectoscope devices market accounted for USD 148.7 million in 2024 and is anticipated to grow at a CAGR of 4.9% between 2025 to 2034 period.
 

• The widespread availability of advanced surgical equipment and the presence of leading market players offering innovative resectoscope solutions drive the market in the U.S.
   
• Additionally, strong healthcare spending, a growing elderly population, and a high rate of minimally invasive surgical procedures contribute significantly to the country's leadership position.
   

France resectoscope devices market is projected to grow remarkably in the coming years.
 

• The increasing incidence of conditions like BPH among the aging population, coupled with the adoption of advanced surgical technologies, has fueled demand for resectoscope devices.
   
• France focus on improving surgical outcomes through training programs and investments in healthcare innovation further reinforces its significant market share.
   

China holds a dominant position in the Asia Pacific resectoscope devices market.
 

• The rising prevalence of urological and gynecological disorders, along with government initiatives to modernize healthcare facilities, has boosted the demand for resectoscope devices.
   
• China’s increasing adoption of minimally invasive surgical techniques, along with a growing number of skilled healthcare professionals, positions it as a rapidly growing market with significant potential.
   

Resectoscope Devices Market Share

Several key players in the market are making strides in product innovation and strategic partnerships to maintain market leadership. Companies are investing heavily in R&D to develop advanced resectoscope devices with enhanced features such as enhanced visualization capabilities, user-friendly designs, and improved safety features. Additionally, partnerships with healthcare providers are being forged to improve product accessibility in emerging markets. Regulatory compliance and adherence to international quality standards are crucial aspects of the strategies employed by these companies to cater to a global market. These developments are helping companies meet the increasing demand for safe and efficient resectoscope devices.
 

Resectoscope Devices Market Companies

Prominent players operating in the resectoscope devices industry include:

• Advin Urology
• bissinger
• ESC Medicams
• ENDOMED SYSTEMS
• JDmeditech
• KARL STORZ
• LEPU MEDICAL
• OLYMPUS
• Orion Medical
• Richard Wolf
• Stryker
• TONTARRA
   

Resectoscope Devices Industry News:

• In November 2024, Olympus Corporation of the Americas showcased a comprehensive range of gynecological solutions at the American Association of Gynecological Laparoscopists (AAGL) World Congress in New Orleans. Key innovations included the 8.5 MM Hystero-Resectoscope for advanced plasma hysteroscopic resection and the VERSAPOINT II Bipolar Electrosurgery System. These devices are designed to enhance precision and safety in gynecological procedures, addressing the growing demand for minimally invasive surgical options.
   

The resectoscope devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Monopolar resectoscopes
• Bipolar resectoscopes
• Hybrid resectoscopes

Market, By Application

• Urology
• Gynecology
• General surgery
• Other applications

Market, By End Use

• Hospitals
• Clinics
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE